Top companies

ASIANPAINT - 2472.2 (1.81%) AXISBANK - 1142.4 (0.29%) BAJAJFINSV - 1600.85 (2.01%) BAJFINANCE - 6683.95 (3.38%) BHARTIARTL - 1569.3 (2.89%) BPCL - 285.85 (1.22%) COALINDIA - 414.05 (1.98%) HDFCBANK - 1745.6 (0.25%) HEROMOTOCO - 4794.1 (0.55%) HINDUNILVR - 2445.25 (2.62%) ICICIBANK - 1278.05 (2.2%) INDUSINDBK - 998.2 (1.71%) ITC - 474.65 (3.83%) KOTAKBANK - 1761.45 (1.4%) MARUTI - 11063.6 (1.86%) ONGC - 245.6 (1.42%) RELIANCE - 1265.4 (3.47%) SBIN - 816.05 (4.52%) TATAMOTORS - 791 (2.22%) TATASTEEL - 142.78 (1.83%) TCS - 4244.6 (4.22%) TITAN - 3308.7 (4.1%) WIPRO - 571.65 (2.6%)

Quick Menu

TRENDING #Zee Entertainment Enterprises Limited1

Windlas Biotech 

Sector: Biotechnology & Medical Research

Windlas Biotech 

961.7   35.1 (3.79%)

As on 24 Nov, 2024 10:43 IST
Prediction
Open 922
LTP 961.7
Previous Close 926.6
Day High 992.9
Day Low 905.25
Volume 72425

Overview

Code : WINDLAS
Name : Windlas Biotech Limited
Country : India
Sector : Biotechnology & Medical Research
Industry: Drug Manufacturers - Specialty & Generic
Market CAP : 2,012 Cr
Stock P/E: 32.89
ROCE: 13.66%
Book Value: 216.33
Dividend Yield : 0.54%
Most Recent Quarter : 2024-09-30
Revenue/Sales TTM : 661 Cr
Operating Margin TTM : 0.0838%
Return On Equity TTM : 0.14%
Profit Margin : 0.09%
Market Capitalization : 2,012 Cr
EBITDA : 80 Cr
Book Value : 216.33
PERatio : 32.89
Dividend Share : 0
Earnings Share : 29.24
Gross Profit TTM : 158 Cr
Quarterly Earnings Growth YOY : 0.11%
Dividend Yield : 0.0054%
Quarterly Revenue GrowthYOY : 0.21
Diluted Eps TTM : 29.24
Trailing PE : 32.89
Price Sales TTM : 3.04
Enter Prise Value : 1,816 Cr
Enter Prise Value Ebidta : 17.6532
Forward PE : 0
Price Book MRQ : 4.27
Enter Prise Value Revenue : 2.62
Shares Outstanding : 20,900,300
Percent Insiders : 62.513%
Shares Short :
Short Ratio :
Short Percent Float :
Shares Float : 7,809,695
Percent Institutions : 8.097%
Shares Short Prior Month :
Short Percent Outstanding :
Forward Annual Dividend Rate : 5.5
Payout Ratio : 0.14
Ex Dividend Date : 2024-09-17
Last Split Date : 0000-00-00
Forward Annual Dividend Yield : 0.0054
Dividend Date :
Last Split Factor :

Advanced Chart

GM Stock Technicals

PIVOT LEVELS
Type R1 R2 R3 PP S1 S2 S3
Classic 1001.32 1040.93 1088.97 953.28 913.67 865.63 826.02
Fibonacci 985.68 1033.11 1073.33 945.46 898.03 857.81 810.38
Camarilla 1005.53 1043.04 1093.18 955.39 917.88 867.74 830.23
Classic 965.83 1023.19 1053.48 935.54 878.18 847.89 790.53

Moving Averages

Days
50 Day MA		 950.27
Days
200 Day MA		 723.15
Days
52 Week High		 1198.25
Days
52 Week Low		 397.62

Financials

Quarterly Sale Expense Net Income Other Operating Expenses Interest Expense Tax Provision EBIT NetInterest Income Income Tax Expense
Sep 2024 187 Cr 71 Cr 16 Cr 187 Cr 1 Cr 0 21 Cr 0 5 Cr
Jun 2024 175 Cr 17 Cr 13 Cr 160 Cr 49 Lac 5 Cr 19 Cr 0 Cr 5 Cr
Mar 2024 171 Cr 19 Cr 17 Cr 153 Cr 28 Lac 6 Cr 23 Cr 0 Cr 6 Cr
Dec 2023 162 Cr 44 Cr 15 Cr 145 Cr 31 Lac 5 Cr 20 Cr 0 Cr 5 Cr
Yearly Sale Expense Net Income Other Operating Expenses Interest Expense Tax Provision Interest Income Net Interest Income Income Tax Expense
Mar 2024 631 Cr 101 Cr 58 Cr 501 Cr 1 Cr 19 Cr 0 -1 Cr 19 Cr
Mar 2023 513 Cr 140 Cr 43 Cr 465 Cr 79 Lac 14 Cr 3 Cr -1 Cr 14 Cr
Mar 2022 463 Cr 120 Cr 38 Cr 423 Cr 1 Cr 7 Cr 4 Cr -1 Cr 7 Cr
Mar 2021 427 Cr 108 Cr 16 Cr 382 Cr 1 Cr 6 Cr 2 Cr 63 Lac 6 Cr
//14295470000000 //14295470000000 //14295470000000 //14295470000000
Quarterly Total Assets Total Current Assets Inventory Total Liab Other Liab Total Current Liabilities Total Stock holder Equity
Sep 2024 747 Cr 517 Cr 82 Cr 276 Cr 0 271 Cr 471 Cr
Jun 2024 0 204 Cr 0 -450 Cr 0 0 450 Cr
Mar 2024 626 Cr 431 Cr 62 Cr 176 Cr 0 172 Cr 450 Cr
Dec 2023 0 169 Cr 0 0 0 0 416 Cr
Yearly Total Assets Total Current Assets Inventory Total Liab Other Liab Total Current Liabilities Total Stock holder Equity
Mar 2024 626 Cr 431 Cr 62 Cr 176 Cr 0 172 Cr 450 Cr
Mar 2023 529 Cr 354 Cr 75 Cr 127 Cr 0 121 Cr 402 Cr
Mar 2022 491 Cr 382 Cr 59 Cr 96 Cr 2 Cr 94 Cr 395 Cr
Mar 2021 296 Cr 194 Cr 41 Cr 97 Cr 2 Cr 93 Cr 199 Cr
Quarterly Change To Net income Dividends Paid Change To Inventory Investments Net Income Depreciation Capital Expenditures
Jun 2024 0 0 0 0 13 Cr 0 0
Mar 2024 0 0 0 0 17 Cr 0 0
Dec 2023 0 0 0 0 15 Cr 3 Cr 0
Sep 2023 0 0 0 0 14 Cr 3 Cr 0
Yearly Change To Net income Dividends Paid Change To Inventory Investments Net Income Depreciation Capital Expenditures
Mar 2024 0 -8 Cr 13 Cr -92 Cr 58 Cr 13 Cr 38 Cr
Mar 2023 0 8 Cr -16 Cr -14 Cr 57 Cr 12 Cr 71 Cr
Mar 2022 -4 Cr 8 Cr -17 Cr -142 Cr 46 Cr 12 Cr 15 Cr
Mar 2021 23 Cr 0 10 Cr 87 Cr 22 Cr 13 Cr 6 Cr

Prediction

Date Target 3 Target 2 Target 1 Trading Levels Target 1 Target 2 Target 3
2024-11-24 835.10 837.20 840.15 843.50
 846.90
 850.25 853.25 855.35

7 Days Historical Data

See More
DateOpening priceClosing priceMinimum priceMaximum price
2024-11-18 1025.05 984.15 980.1 1050
2024-11-19 998.3 958.95 951.2 1028
2024-11-20 958.95 958.95 958.95 958.95
2024-11-21 959 926.6 921.3 985
2024-11-22 922 961.7 905.25 992.9

About Company

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Open 922
LTP 961.7
Previous Close 926.6
Day High 992.9
Day Low 905.25
Volume 72425

Peers

Company Name Price Change % Chg Day High Day Low Previous Close Volume
Biocon  0 0 0 0 0 0 0

Top Gainers

Company
SBIN 		LTP
816.05 		Change
35.3 		Gain
4.52 %
Company
TCS 		LTP
4244.6 		Change
171.75 		Gain
4.22 %
Company
TITAN 		LTP
3308.7 		Change
130.25 		Gain
4.1 %
Company
ITC 		LTP
474.65 		Change
17.5 		Gain
3.83 %
Company
RELIANCE 		LTP
1265.4 		Change
42.4 		Gain
3.47 %

Top Losers

Company
HDFCBANK 		LTP
1745.6 		Change
4.4 		Loss
4.4 %
Company
AXISBANK 		LTP
1142.4 		Change
3.25 		Loss
3.25 %
Company
HEROMOTOCO 		LTP
4794.1 		Change
26.25 		Loss
26.25 %
Company
BPCL 		LTP
285.85 		Change
3.45 		Loss
3.45 %
Company
KOTAKBANK 		LTP
1761.45 		Change
24.35 		Loss
24.35 %

News
By Kanchan Joshi  |  10 Aug, 2021

Windlas Biotech IPO: GMP, allotment date and how to check application status

Windlas Biotech IPO: After the closure of Windlas Biotech IPO subscription, bidders are anxiously waiting for the share allotment date, which is 11th August 2021. According to market observers, the public issue received reasonable response as it got subscribed little over 22 times. They went on to add that grey market too is expecting reasonable gains as Windlas Biotech IPO GMP today is Rs80, whic...
By Kanchan Joshi  |  07 Aug, 2021

Krsnaa Diagnostics, Devyani International, Windlas Biotech, Exxaro Tiles IPOs: GMPs, allotment dates

Krsnaa Diagnostics, Devyani International, Windlas Biotech, Exxaro Tiles IPOs: The three day subscription for Krsnaa Diagnostics, Devyani International, Windlas Biotech and Exxaro Tiles IPOs ended yesterday. After the end of bidding Krsnaa Diagnostics IPO has been subscribed 64.38 times, Devyani International IPO got subscribed huge 116.70 times, Windlas Biotech IPO got subscribed 22.44 times whil...
By Kanchan Joshi  |  04 Aug, 2021

Windlas Biotech IPO: GMP, subscription status, and other details

Windlas Biotech, manufacturer of pharmaceutical formulations, initial public offer (IPO) opens for subscription today and the three-day issue will conclude on August 6. The price band has been fixed at Rs448-460 a share for the public offering. The IPO comprises fresh issuance of equity shares worth Rs165 crore and and an offer for sale of up to 5,142,067 equity shares.Within the first two hours o...
By Kanchan Joshi  |  03 Aug, 2021

Windlas Biotech, Devyani International, Krsnaa, Exxaro IPOs: Should you subscribe

Four issues - Windlas Biotech, Devyani International, Exxaro Tiles and Krsnaa Diagnostics, are set to open for subscription tomorrow and the three-days initial public offerings (IPOs) of the firms will conclude on August 6.As per market observers, Windlas Biotech grey market premium (GMP) is strong at over Rs140 whereas Devyani International shares are available at a premium (GMP) of Rs62. Krsnaa ...
By Kanchan Joshi  |  30 Jul, 2021

Windlas Biotech IPO to open for subscription next week. Key details to know

Manufacturer of pharmaceutical formulations Windlas Biotech will launch its initial public offering (IPO) next week on Wednesday, August 4. The three-day public issue will conclude on August 6 and the company has fixed the price band of the initial share sale at Rs448-460 per share.The Windlas Biotech IPO comprises fresh issuance of equity shares worth Rs165 crore and an offer for sale (OFS) of up...

Forum

Community Sentiments

WINDLAS Stock Sentiment

As on 24 Nov, 2024 10:43 IST

Buy Sell Hold

Login & Comment

SEMU 2022-08-04 11:16:55

target 400 in six month 👍👍👍👍👍

Login & Reply Like(0) Dislike(0) Repost Spam

Growmudra © 2024 all right reserved

Partner With Us